| Ovarian cancer immunotherapy and personalized medicine S Morand, M Devanaboyina, H Staats, L Stanbery, J Nemunaitis International Journal of Molecular Sciences 22 (12), 6532, 2021 | 271 | 2021 |
| Current ovarian cancer maintenance strategies and promising new developments V Gogineni, S Morand, H Staats, R Royfman, M Devanaboyina, K Einloth, ... Journal of Cancer 12 (1), 38, 2021 | 60 | 2021 |
| Natural killer cells: a review of biology, therapeutic potential and challenges in treatment of solid tumors K Choucair, JR Duff, CS Cassidy, MT Albrethsen, JD Kelso, A Lenhard, ... Future oncology 15 (26), 3053-3069, 2019 | 55 | 2019 |
| Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment S Morand, H Staats, JF Creeden, A Iqbal, B Kahaleh, L Stanbery, ... Future Oncology 16 (9), 483-495, 2020 | 32 | 2020 |
| Targeted molecular therapy in palliative cancer management H Staats, C Cassidy, J Kelso, S Mack, S Morand, K Choucair, H Qaqish, ... Insights Biomed 5 (3), 2020 | 7 | 2020 |
| COVID-19 and aortic thrombosis: A case report M Balla, H Staats-Ciotola, M Dhavale, V Sangani, M Pokal, GP Merugu, ... Journal of Community Hospital Internal Medicine Perspectives 12 (3), 94, 2022 | 2 | 2022 |
| Science Repository M Devanaboyina, N Ngo, R Albalawy, L Filipiak, H Staats, L Stanbery, ... | | 2021 |
